Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01555567 · ClinicalTrials.gov registry record · NA

Electrical Stimulation and Eccentric Exercise for Anterior Cruciate Ligament (ACL) Injury

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
43
Enrollment target

NCT01555567: Completed NA study, sponsored by University of Michigan.

NCT01555567 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 43 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01555567, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target

Study Summary

Quadriceps muscle weakness is a common consequence of ACL injury. This muscle weakness is considered to result from neural inhibition preventing full muscle contraction and is referred to as arthrogenic muscle inhibition (AMI). AMI hinders rehabilitation by preventing gains in strength, increasing the risk of re-injury, and potentially placing patients at risk for chronic degenerative joint conditions. Quadriceps weakness that occurs following ACL injury is also thought to be caused by muscle atrophy which is thought to manifest due to alterations in muscle architecture, selective fiber atrophy or even neural deficits such as AMI. Importantly, interventions that are designed to counter this muscle weakness are required in order to promote long-term knee joint health. Hence, the purpose of the current study is to determine the efficacy of interventions that target quadriceps weakness to improve quadriceps muscle function and biomechanics in patients prior to and following ACL reconstruction. Specifically, the efficacy of neuromuscular electrical stimulation aimed at improving quadriceps neural activity and eccentric exercise intended to minimize quadriceps muscle atrophy will be investigated. The investigators expect that patients who receive the electrical stimulation therapy will demonstrate improvements in quadriceps strength and activation. Furthermore, it is expected that patients who receive both the electrical stimulation and eccentric intervention will demonstrate markedly greater gains in quadriceps strength and activation than patients who receive only the electrical stimulation therapy or standard of care post-surgery. The investigators also hypothesize that the patients who receive the electrical stimulation therapy and/or eccentrics will display knee motion similar to uninjured control subjects.

Interventions

  • DEVICE Electrical Stimulation
  • OTHER Eccentric Exercise

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2009-08
Est. Completion 2014-07
Phase NA
University of Michigan

1,327 total trials

What the finished NCT01555567 record still lists

NCT01555567 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Electrical Stimulation is the first listed.

NCT01555567 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01555567 about?

NCT01555567 is a clinical study titled "Electrical Stimulation and Eccentric Exercise for Anterior Cruciate Ligament (ACL) Injury". Quadriceps muscle weakness is a common consequence of ACL injury. This muscle weakness is considered to result from neural inhibition preventing full muscle contraction and is referred to as arthrogenic muscle inhibition (AMI). AMI hinders rehabilitation by preventing gains in strength, increasing t...

What is the current status of trial NCT01555567?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2009-08. Estimated completion is 2014-07.

What interventions are being tested in trial NCT01555567?

The interventions under investigation include: Electrical Stimulation (DEVICE), Eccentric Exercise (OTHER).

Who is sponsoring clinical trial NCT01555567?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01555567's enrollment target sits among peer trials

43 1435th of 2000 higher than 565 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03726359 · 43 participants · Phase 1

    Phase I Study of Fractionated Stereotactic Radiation Therapy

  • NCT03850418 · 43 participants · Phase 2

    Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

  • NCT04144023 · 43 participants · Phase 1

    A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

  • NCT04176718 · 43 participants · Phase 2

    Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01555567, the US trial registry maintained by the National Library of Medicine. NCT01555567 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.